Effect of integrin β8 on TGF-β1 activation in astrocytes with oxygen glucose deprivation
LI Jin-Hui, LI De-Yuan, CHEN Da-Peng, MU De-Zhi, QU Yi
Department of Pediatrics, West China Second Hospital, Sichuan University; West China Children's Medical Center; Key Laboratory of Obstetric & Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, Chengdu 610041, China
Abstract：Objective To study the effect of β8 expression on transforming growth factor β1(TGF-β1) activation in astrocytes with oxygen glucose deprivation (OGD). Methods Astrocytes were cultured and then subjected to OGD to generate hypoxia-ischemia (HI) model in vitro. Immunocytochemistry was used to detect the expression and distribution of β8 in nomoxia cultured cells. β8 protein expression was quantified by Western blot at 12 hours, 1 day and 2 days after OGD. Astrocytes and luciferase reporter cells (TMLC) were co-cultured. β8 RNA interference system was established to specifically inhibit β8 expression in cultured astrocytes. TGF-β1 activation was then detected in the co-culture system. Results β8 was mainly located in the cytoplasm and neurites of astrocytes. OGD resulted in increase of β8 protein expression at 12 hours after reoxygenation in astrocytes, which was peaked at 1 day after reoxygenation. TGF-β1 activation was in accordance with β8 expression in astrocyte-TMLC co-culture system after reoxygenation. After the inhibition of β8, TGF-β1 activation was significantly reduced in all time points. Conclusions The highly expressed β8 plays important roles in the regulation of TGF-β1 activation in neonatal rats with hypoxic-ischemic brain damage.
LI Jin-Hui,LI De-Yuan,CHEN Da-Peng et al. Effect of integrin β8 on TGF-β1 activation in astrocytes with oxygen glucose deprivation[J]. CJCP, 2014, 16(1): 73-76.
Chaboub LS, Deneen B. Developmental origins of astrocyte heterogeneity: the final frontier of CNS development[J]. Dev Neurosci, 2012, 34(5): 379-388.
[2]
Ben Achour S, Pascual O. Astrocyte-neuron communication: functional consequences[J]. Neurochem Res, 2012, 37(11): 2464-2473.
[3]
Katsuno M, Adachi H, Banno H, et al. Transforming growth factor-β signaling in motor neuron diseases[J]. Curr Mol Med, 2011, 11(1): 48-56.
[4]
Mu DZ, Cambier S, Fjellbirkeland L, et al. The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1[J]. J Cell Biol, 2002, 157(3):493-507.
[5]
Nishimura SL, Boylen KP, Einheber S, et al. Synaptic and glial localization of the integrin alphavbeta8 in mouse and rat brain[J]. Brain Res, 1998, 791(1-2): 271-282.
[6]
Li JH, Qu Y, Li XH, et al. The role of integrin alpha(v)beta(8) in neonatal hypoxic-ischemic brain injury[J]. Neurotox Res, 2010, 17(4): 406-417.
[7]
Moreno C, Sampieri A, Vivas O, et al. STIM1 and Orai1 mediate thrombin-induced Ca(2+) influx in rat cortical astrocytes[J]. Cell Calcium, 2012, 52(6): 457-467.
[8]
Abe M, Harpel JG, Metz CN, et al. An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promotor-luciferase construct[J]. Anal Biochem, 1994, 216(2): 276-284.
[9]
Mobley AK, McCarty JH. β8 integrin is essential for neuroblast migration in the rostral migratory stream[J]. Glial, 2011, 59(11): 1579-1187.
[10]
Tchaicha JH, Reyes SB, Shin J, et al. Glioblastoma angiogenesis and tumor cell invasiveness are differentially regulated by β8 integrin[J]. Cancer Res, 2011, 71(20): 6371-6381.
[11]
Kou W, Hu GH, Yao HB, et al. Regulation of transforming growth factor-β1 activation and expression in the tissue remodeling involved in chronic rhinosinusitis[J]. ORL J Otorhinolaryngol Relat, 2012, 74(3):172-178.
[12]
Cambier S, Gline S, Mu DZ, et al. Integrin alpha(v)beta8-mediated activation of transforming growth factor-beta by perivascular astrocyte[J]. Amer J Pathol, 2005, 166(6): 1883-1894.
[13]
Milner R, Relvas JB, Fawcett J, et al. Development regulation of alphav integrins produces functional changes in astrocyte behavior[J]. Mol Cell Neurosci, 2001, 18: 108-118.
[14]
Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities[J]. Nat Rev Cancer, 2010, 10(1): 9-22.
